Key Takeaways
- Revenue up 28% but gross profit lagged: Gross profit grew only 12% YoY, trailing industry production growth, though management attributes the gap to WIP timing within the auto value chain rather than market share loss.
- Lightweighting orders are stacking up, not yet converting: Multiple new control arm and link orders were announced this quarter, but SOPs stretch into FY27 and FY28, so the revenue payoff is still ahead.
- Export pipeline is building, with trade deals as tailwinds: New North American export orders and sample shipments signal progress, while the India-U.S. and India-EU trade deals improve long-term sourcing confidence.
- Regulatory timelines are slipping, which defers capex but also defers content uplift: TREM5 faces a likely delay or change, and no capex has been initiated; BS7 is being monitored but no date is set.
- What to watch next quarter: Whether the Uttarakhand facility ramp-up stays on track for high utilization within FY27, any further clarity on TREM5 contours, and conversion of the Donghee partnership into tangible customer engagements.
Revenue Growth vs. Gross Profit: The WIP Gap
- Topline outpaced gross profit by a wide margin: Revenue grew 28% YoY while gross profit grew only 12%, below PV production growth of 19% and LCV growth of 16%.
- Management's explanation is WIP timing: Parts flow into engines, then engine inventory, then final assembly, making quarterly matching between Sharda's shipments and end-industry production difficult. Management stated gross profit remains the better indicator of underlying operating performance.
- Catalyst pass-through creates an optical drag: Catalyst costs are either customer-directed purchases or supplied free of cost, so Sharda bears no commodity risk. But when Sharda buys and passes through, the cost inflates both revenue and cost of goods sold, optically compressing margins on a percentage basis with no actual deterioration.
- Other commodity exposure is index-linked: For non-catalyst bought-out components, prices adjust with agreed periodicity to customers via indexation, insulating margins from commodity swings.
- The market share question went unanswered: When asked directly whether the gross profit lag implied market share loss, management reiterated the WIP explanation but did not address the share question.
Relan: "So on a percentage basis, it deteriorates our numbers, if you look at it... It's just optical. This, first of all, there's no deterioration. It's all optical, right? If you adjust the numerator denominator, it will even out, right?"
Lightweighting: Orders In, Revenue Still to Come
- New order wins this quarter: A control arms order from a leading PV OEM (USD0.3 crore annual, USD1.5 crore lifetime, SOP Q3 FY27) plus two volume-increase orders on existing control arm and link programs (combined USD0.5 crore annual, USD2.5 crore lifetime), with one SOP already in Q3 and another in Q4 FY26.
- Donghee partnership adds design capability: The technology licensing agreement transfers design, drawing process know-how and validation protocols for control arms, links, subframes and torsion beams, targeting Indian OEMs including SUVs, EVs and premium vehicles. Business development with customers has started but is a longer B2B process.
- R&D positioning: Sharda has augmented R&D for light weighting and claims to be one of few Indian players with local capabilities on control arms and links, with co-located facilities enabling JIT deliveries.
- Revenue conversion timeline is back-end loaded: Management expects to gain further market share in FY27 and FY28 from orders won over the last two years, but SOPs and ramp-ups mean the payoff is gradual.
- Margins on this business are still unknown: Management said margins of a fully grown lightweighting business with associated economies of scale will be known in due course, declining to provide forward-looking numbers.
Maheshwari: "What they will do is the association with them is transfer of design, drawing process know-how and the validation protocols. We would target market for Indian OEMs, including SUVs and EVs and other premium vehicles, exactly what you mentioned."
Export Business: Samples Shipped, Trade Deals as Tailwinds
- North American orders progressing: Samples were shipped in Q3 FY26 for the previously announced export order (USD0.7 crore annual, USD4 crore lifetime) from the largest North American engine and genset manufacturer. New export orders were also bagged this quarter (aggregate USD0.37 crore annual, USD1.85 crore lifetime), with SOPs commencing gradually from Q3 and Q4 FY27.
- New export orders announced on the call carry an aggregate annual value of USD0.37 crore.
- India-U.S. trade deal framed as structural positive: Management sees it reinforcing Sharda's strategy as a manufacturing base for emission system components, lightweighting components, temperature-controlled tubes and heat shields, improving long-term sourcing confidence among global OEMs and Tier 1 suppliers.
- India-EU trade deal opens European pipeline: The deal supports improved predictability and market access; Sharda has multiple RFQs in hand for the European market and sees good traction, though progress will be updated as it materializes.
- Dedicated export team continues to see a healthy RFQ pipeline, with new customer additions expected over coming quarters.
Maheshwari: "The India U.S. trade deal is a positive structural development for Indian auto component manufacturers. For Sharda, it's a reinforcement of our strategy and positions us as a manufacturing base for emission system components, light weighting components, temperature-controlled tubes and heat shields."
Regulatory Pipeline: Delays Defer Content Uplift
- TREM5 timeline is slipping: No official notification has been issued, and based on customer interactions management says it is evident there will be a delay or a change in implementation. It is difficult to speculate on the revised timeline or exact contours. No capex has been initiated for TREM5.
- Preparatory work is not wasted: TREM5 readiness is already helping secure indirect export opportunities, particularly in tractor exports from India.
- BS6.3 (WLTP) is dated: Effective from 1 April 2027 for vehicles under 3.5-ton gross vehicle weight. Content increase per vehicle is still being worked out per segment and per OEM, and may gradually rise with gross vehicle weight.
- BS7 is on the radar but unfunded: Management is closely monitoring developments, benchmarking products globally, and engaging with customers to co-develop the system, but no date has been notified and no capex has been committed.
- The TREM5 dilution question was deflected: When asked hypothetically whether a scenario where sub-50-horsepower tractors transition to TREM IV instead of TREM V would be meaningful for revenue, management declined to engage, stating "a norm is a norm" and that no official dilution is being discussed.
Maheshwari: "There has been no official notification on TREM5 so far. However, based on customer interactions, it is evident that there would be a delay or a change in the implementation. At this stage, it is difficult to speculate on the revised time line or the exact contours of the regulation as discussions are going on and no formal communication has been issued."
Capacity & Facilities: Uttarakhand Build-Out
- New Uttarakhand facility approved: Capex of approximately ₹20 crores, with modular and scalable capacity. The first phase involves shifting current business as a customer shifts production to that region.
- Ramp-up target is within FY27: Management expects the facility to reach high-capacity utilization within FY27, which would open opportunities to gain more market share from that customer's plant as well as other customers in North India for both emission and lightweighting segments.
- Existing capacity utilization disclosed: On the current 480,000-piece capacity, utilization stood at 80% in Q3, per an analyst's math.
- Content-per-vehicle trajectory remains unanchored: Management did not provide a timeline for the journey from INR2,000 to INR8,000 to INR6,000 to INR18,000 per vehicle, leaving the pace of content expansion uncertain.
JV, M&A and Technology Bets
- Eberspaecher JV remains sub-scale: The JV focuses on the above-4-liter M&HCV segment where its market share is not significant; overall progress has been limited. Sharda does not have management control and consolidates only at the profit level after royalty expenses, so contribution is small. Management expects performance to improve but says overall contribution will not become very significant.
- The reason for the JV's stagnation went unanswered: When asked why the JV has not ramped up meaningfully in two years (profit range-bound at ~₹1 crore), management did not address the question.
- Acquisitions are on the radar but disciplined: Management continues to evaluate opportunities but wants to be very disciplined on valuation and ticket size, and says timing is hard to predict as it depends on what comes back.
- AI is an internal focus, not a product: Sharda is implementing AI across all business functions and processes internally and plans to double and triple down on this. If cross-use opportunities emerge between AI and lightweighting technology, it is very early.
- Technology scouting is active: Management is very actively looking at two specific countries for technology scouting, though details were not disclosed.
Maheshwari: "For acquisitions, we continue to evaluate opportunities. However, we want to be very disciplined on the valuation and ticket size. It is hard to time this as it's really based on what comes back."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Uttarakhand facility ramp-up | Reach high-capacity utilization; opens North India market share opportunities for emission and lightweighting segments | Within FY27 |
| Lightweighting market share gains | Gain further market share from multiple order wins over last 2 years | FY27 and FY28 |
| Suspension business growth | Significant growth in view of already announced orders; SOPs in FY26, gradual ramp-up in FY27 | FY27 and FY28 |
| Export order SOPs | Samples shipped; SOPs for USD0.7 crore lifetime value orders | Q2 FY27 |
| New export customer additions | Supported by dedicated export-focused team and healthy RFQ pipeline | Over coming quarters |
| Product-wise revenue split disclosure | Working on methodology; will share more details to help understand breakup | Most likely from next year |
| TREM5 capex | No capex initiated; awaiting official notification | No timeline (dependent on regulation) |
| BS7 readiness | Monitoring, benchmarking, co-developing with customers; no date notified | No timeline (dependent on regulation) |
Key Metrics
| Metric | Q3 FY26 |
|---|---|
| Revenue | ₹881.6 cr, +28% YoY |
| Gross profit | ₹202.3 cr, +12% YoY |
| EBITDA | ₹106.4 cr, +13% YoY; margin at 12.1% |
| PBT (before exceptional items) | ₹111.6 cr, vs ₹100.8 cr in Q3 FY25 |
| PAT | ₹81.4 cr |
| Impact of New Labour Codes | ₹4.5 cr exceptional loss recorded in Q3 |
| 9M FY26 revenue | ₹2,425 cr, +16% YoY |
| 9M FY26 PAT | ₹256 cr, vs ₹231 cr in 9M FY25 |
| Emission vertical revenue share | 88% of top line (FY25 annual basis) |
| Light weighting (suspension) revenue share | 9% of top line (FY25 annual basis) |
| CV revenue share | ~40%; PV ~46% (FY25 annual basis) |
| Export revenue share | ~1% of overall company revenues in FY25 |
| Light weighting capacity utilization | ~80% on existing 480,000 pieces capacity |
| JV and associates profit contribution | A little over ₹1 cr in Q3, similar for full financial year |
| Patents filed (cumulative) | 20 filed; 4 awarded (1 awarded in Q3) |
| New Uttarakhand facility capex | ~₹20 cr; high utilization expected within FY27 |